Stocklytics Platform
Asset logo for symbol BIO
Bio-Rad Laboratories
BIO48
$260.03arrow_drop_up1.17%$3.02
Asset logo for symbol BIO
BIO48

$260.03

arrow_drop_up1.17%

Performance History

Chart placeholder
Key Stats
Open$257.30
Prev. Close$257.00
EPS-65.36
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range253.56
260.17
52 Week Range243.35
428.05
Ratios
EPS-65.36

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories Inc (BIO) is an American multinational company that provides a wide range of products and solutions for the life science research and clinical diagnostic markets. With a history spanning over six decades, Bio-Rad has established itself as a leader in the industry, known for its cutting-edge technologies and innovative products. The company operates in two main segments: Life Science and Clinical Diagnostics. The Life Science segment offers a comprehensive portfolio of tools and reagents for research purposes, including genomics, proteomics, cell biology, and food safety. The Clinical Diagnostics segment provides a variety of diagnostic tests and systems for the detection and monitoring of diseases, such as autoimmune disorders, diabetes, and cancer.
Bio-Rad Laboratories Inc is committed to advancing scientific discovery and improving patient care through its high-quality products and solutions. The company's extensive product portfolio is backed by a strong research and development team, which is dedicated to developing innovative solutions to address the evolving needs of the scientific and medical communities. Bio-Rad has a global presence, with customers in more than 100 countries worldwide. The company's strong market position is reflected in its financial performance, with consistent revenue growth and a strong balance sheet. As of [date], Bio-Rad Laboratories Inc has a market capitalization of [market cap], making it one of the largest companies in the industry. The company's stock, with the ticker symbol BIO, is listed on [stock exchange] and has been performing well, with a 52-week range of [52-week range] and a trading volume of [trading volume]. The stock's PEG ratio, which measures its valuation relative to its expected earnings growth, is [PEG ratio]. In comparison to its industry peers, Bio-Rad Laboratories Inc has demonstrated strong financial performance and market position.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Norman D. Schwartz
Headquarters
Hercules
Employees
8200
Exchange
NYSE
add Bio-Rad Laboratories  to watchlist

Keep an eye on Bio-Rad Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Bio-Rad Laboratories 's (BIO) price per share?

The current price per share for Bio-Rad Laboratories (BIO) is $260.03. The stock has seen a price change of $3.03 recently, indicating a 1.18% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Bio-Rad Laboratories (BIO)?

For Bio-Rad Laboratories (BIO), the 52-week high is $428.05, which is 64.62% from the current price. The 52-week low is $243.35, the current price is 6.85% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Bio-Rad Laboratories (BIO) a growth stock?

Bio-Rad Laboratories (BIO) has shown an average price growth of -1.65% over the past three years. It has received a score of 19 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bio-Rad Laboratories as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Bio-Rad Laboratories (BIO) stock price performance year to date (YTD)?

As of the latest data, Bio-Rad Laboratories (BIO) has a year-to-date price change of -20.85%. Over the past month, the stock has experienced a price change of -8.18%. Over the last three months, the change has been -19.73%. Over the past six months, the figure is -23.62%. Looking at a longer horizon, the five-year price change stands at -27.57%.
help

Is Bio-Rad Laboratories (BIO) a profitable company?

Bio-Rad Laboratories (BIO) has a net income of -$99.4M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 53.73% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 8.68% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.57B, although specific revenue growth data is currently not available. The gross profit is $1.38B. Operating income is noted at $269M. Furthermore, the EBITDA is $504.2M.
help

What is the market capitalization of Bio-Rad Laboratories (BIO)?

Bio-Rad Laboratories (BIO) has a market capitalization of $7.28B. The average daily trading volume is 258.33, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level